Patient Perspectives and Side-Effects Experience on Chemotherapy of Non-Small Cell Lung Cancer: A Qualitative Study

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Levitsky A, Pernemalm M, Bernhardson B-M, et al. Early symptoms and sensations as predictors of lung cancer: a machine learning multivariate model. Sci Rep. 2019;9(1):16504. doi:10.1038/s41598-019-52915-x
   PubMedGoogle Scholar
• Sheikh HS, Munawar K, Sheikh F, Qamar MF. Lung cancer in Pakistan. J Thor Oncol. 2022;17(5):602–607. doi:10.1016/j.jtho.2022.01.009
   PubMed Web of Science ®Google Scholar
• Xu F, Cui W, Liu C, et al. Prognostic biomarkers correlated with immune infiltration in non‐small cell lung cancer. FEBS Open Bio. 2023;13(1):72–88. doi:10.1002/2211-5463.13501
   PubMed Web of Science ®Google Scholar
• Provencio M, Calvo V, Romero A, Spicer JD, Cruz-Bermúdez A. Treatment sequencing in resectable lung cancer: the good and the bad of adjuvant versus neoadjuvant therapy. Am Soc Clin Oncol Educl Book. 2022;42:711–728. doi:10.1200/EDBK_358995
   Google Scholar
• Wu L, Hafiz MZ, Guan Y, et al. 17β-estradiol suppresses carboxylesterases by activating c-Jun/AP-1 pathway in primary human and mouse hepatocytes. Eur J Pharmacol. 2018;819:98–107. doi:10.1016/j.ejphar.2017.11.036
   PubMed Web of Science ®Google Scholar
• Zhou N, Wang W, Li H, Jiang D, Zhong X. Development and investigation of dual potent anticancer drug-loaded nanoparticles for the treatment of lung cancer therapy. Process Biochem. 2021;106:42–49. doi:10.1016/j.procbio.2021.03.018
   Web of Science ®Google Scholar
• Jansman FG, Sleijfer DT, de Graaf JC, Coenen JL, Brouwers JR. Management of chemotherapy-induced adverse effects in the treatment of colorectal cancer. Drug Safety. 2001;24(5):353–367. doi:10.2165/00002018-200124050-00002
   PubMed Web of Science ®Google Scholar
• Ganesan P, Sagar TG, Dubashi B, et al. Nonadherence to imatinib adversely affects event free survival in chronic phase chronic myeloid leukemia. Am J Hematol. 2011;86(6):471–474. doi:10.1002/ajh.22019
   PubMed Web of Science ®Google Scholar
• Kondryn HJ, Edmondson CL, Hill J, Eden TO. Treatment non-adherence in teenage and young adult patients with cancer. Lancet Oncol. 2011;12(1):100–108. doi:10.1016/S1470-2045(10)70069-3
   PubMed Web of Science ®Google Scholar
• Islam K, Anggondowati T, Deviany P, et al. Patient preferences of chemotherapy treatment options and tolerance of chemotherapy side effects in advanced stage lung cancer. BMC Cancer. 2019;19(1):1–9. doi:10.1186/s12885-019-6054-x
   PubMed Web of Science ®Google Scholar
• Janssen EM, Dy SM, Meara AS, et al. Analysis of patient preferences in lung cancer–estimating acceptable tradeoffs between treatment benefit and side effects. Patient Prefer Adher. 2020;14:927–937.
   Google Scholar
• Bridges JF, Mohamed AF, Finnern HW, Woehl A, Hauber AB. Patients’ preferences for treatment outcomes for advanced non-small cell lung cancer: a conjoint analysis. Lung Cancer. 2012;77(1):224–231. doi:10.1016/j.lungcan.2012.01.016
   PubMed Web of Science ®Google Scholar
• Yang L, Wang S, Zhou Y, et al. Evaluation of the 7th and 8th editions of the AJCC/UICC TNM staging systems for lung cancer in a large North American cohort. Oncotarget. 2017;8(40):66784. doi:10.18632/oncotarget.18158
   PubMedGoogle Scholar
• Aslam MS, Naveed S, Ahmed A, Abbas Z, Gull I, Athar MA. Side effects of chemotherapy in cancer patients and evaluation of patients opinion about starvation based differential chemotherapy. J Cancer Ther. 2014;5:6.
   Google Scholar
• Al‐Taie A, Izzettin FV, Sancar M, Köseoğlu A. Impact of clinical pharmacy recommendations and patient counselling program among patients with diabetes and cancer in outpatient oncology setting. Eur J Cancer Care. 2020;29(5):e13261. doi:10.1111/ecc.13261
   PubMed Web of Science ®Google Scholar
• Fafouti M, Paparrigopoulos T, Zervas Y, et al. Depression, anxiety and general psychopathology in breast cancer patients: a cross-sectional control study. In vivo. 2010;24(5):803–810.
   PubMed Web of Science ®Google Scholar
• Mohd-Sidik S, Akhtari-Zavare M, Periasamy U, Rampal L, Fadhilah SI, Mahmud R. Effectiveness of chemotherapy counselling on self-esteem and psychological affects among cancer patients in Malaysia: randomized controlled trial. Patient Educ Couns. 2018;101(5):862–871. doi:10.1016/j.pec.2018.01.004
   PubMed Web of Science ®Google Scholar
• Yates JS, Mustian KM, Morrow GR, et al. Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer. 2005;13(10):806–811. doi:10.1007/s00520-004-0770-7
   PubMed Web of Science ®Google Scholar
• Toygar I, Yeşilbalkan ÖU, Kürkütlü M, Aslan A. Complementary and alternative medicines used by cancer patients to cope with chemotherapy-induced constipation. Complement Ther Clin Pract. 2020;39:101108. doi:10.1016/j.ctcp.2020.101108
   PubMed Web of Science ®Google Scholar
• Johnson SB, Park HS, Gross CP, Yu JB. Use of alternative medicine for cancer and its impact on survival. JNCI. 2018;110(1):121–124. doi:10.1093/jnci/djx145
   Google Scholar
• Koehl B, Muenstedt K, Micke O, et al. Survey of German non-medical practitioners regarding complementary and alternative medicine in oncology. Oncol Res Treat. 2014;37(1–2):49–53. doi:10.1159/000358158
   PubMed Web of Science ®Google Scholar
• de Jong FA, Sparreboom A, Verweij J, Mathijssen RH. Lifestyle habits as a contributor to anti-cancer treatment failure. Eur J Cancer. 2008;44(3):374–382. doi:10.1016/j.ejca.2007.12.012
   PubMed Web of Science ®Google Scholar
• Meade CD, McKinney WP, Barnas GP. Educating patients with limited literacy skills: the effectiveness of printed and videotaped materials about colon cancer. Am J Public Health. 1994;84(1):119–121. doi:10.2105/AJPH.84.1.119
   PubMed Web of Science ®Google Scholar
• Levit LA, Byatt L, Lyss AP, et al. Closing the rural cancer care gap: three institutional approaches. JCO Oncol Pract. 2020;16(7):422–430. doi:10.1200/OP.20.00174
   PubMedGoogle Scholar
• Lutgendorf SK, Ramirez E, Schrepf A, et al. Rural residence is related to shorter survival in epithelial ovarian cancer patients. Gynecol Oncol. 2021;163(1):22–28. doi:10.1016/j.ygyno.2021.07.035
   PubMed Web of Science ®Google Scholar
• Golant M, Altman T, Martin C. Managing cancer side effects to improve quality of life: a cancer psychoeducation program. Cancer Nurs. 2003;26(1):37–44. doi:10.1097/00002820-200302000-00005
   PubMed Web of Science ®Google Scholar
• Pei-Hua W, Shang-Wen C, Huang W-T, Chang S-C, Mei-Chi H. Effects of a psychoeducational intervention in patients with breast cancer undergoing chemotherapy. J Nurs Res. 2018;26(4):266–279. doi:10.1097/jnr.0000000000000252
   PubMedGoogle Scholar
• Duncan M, Moschopoulou E, Herrington E, et al. Review of systematic reviews of non-pharmacological interventions to improve quality of life in cancer survivors. BMJ open. 2017;7(11):e015860. doi:10.1136/bmjopen-2017-015860
   PubMed Web of Science ®Google Scholar
• Papagrigoriadis S, Heyman B. Patients’ views on follow up of colorectal cancer: implications for risk communication and decision making. Postgrad Med J. 2003;79(933):403–407. doi:10.1136/pmj.79.933.403
   PubMed Web of Science ®Google Scholar
• Bergkvist K, Wengström Y. Symptom experiences during chemotherapy treatment—with focus on nausea and vomiting. Eur J Oncol Nurs. 2006;10(1):21–29. doi:10.1016/j.ejon.2005.03.007
   PubMed Web of Science ®Google Scholar
• Teston EF, Fukumori EFC, Benedetti G, Spigolon DN, Costa MAR, Marcon SS. Feelings and difficulties experienced by cancer patients along the diagnostic and therapeutic itineraries. Escola Anna Nery. 2018;22. doi:10.1590/2177-9465-ean-2018-0017
   Google Scholar
• Rotegård AK, Fagermoen MS, Ruland CM. Cancer patients’ experiences of their personal strengths through illness and recovery. Cancer Nurs. 2012;35(1):E8–E17. doi:10.1097/NCC.0b013e3182116497
   PubMed Web of Science ®Google Scholar
• Novakovic B, Fears TR, Wexler LH, et al. Experiences of cancer in children and adolescents. Cancer Nurs. 1996;19(1):54–59. doi:10.1097/00002820-199602000-00007
   PubMed Web of Science ®Google Scholar
• Barre PV, Padmaja G, Rana S. Stress and quality of life in cancer patients: medical and psychological intervention. Indian J Psychol Med. 2018;40(3):232–238. doi:10.4103/IJPSYM.IJPSYM_512_17
   PubMedGoogle Scholar
• Fitch M, Longo CJ. Exploring the impact of out-of-pocket costs on the quality of life of Canadian cancer patients. J Psychosoc Oncol. 2018;36(5):582–596. doi:10.1080/07347332.2018.1486937
   PubMed Web of Science ®Google Scholar
• Knight TG, Deal AM, Dusetzina SB, et al. Financial toxicity in adults with cancer: adverse outcomes and noncompliance. J Oncol Pract. 2018;14(11):e665–e673. doi:10.1200/JOP.18.00120
   PubMed Web of Science ®Google Scholar
• Lentz R, Benson III AB, Kircher S. Financial toxicity in cancer care: prevalence, causes, consequences, and reduction strategies. J Surg Oncol. 2019;120(1):85–92. doi:10.1002/jso.25374
   PubMed Web of Science ®Google Scholar
• Chiu SYR, Yang Z. Influence of family income and medical insurance coverage on health‐related quality of life and optimism in cancer patients at a Hong Kong private hospital: a cross‐sectional study. Psycho Oncol. 2019;28(10):1971–1977. doi:10.1002/pon.5175
   PubMed Web of Science ®Google Scholar
• Shin J, Yoon J, Shin A, Diaz A. The influence of insurance status on treatment and outcomes in oral cavity cancer: an analysis on 46,373 patients. Int J Oral Maxillofac Surg. 2018;47(10):1250–1257. doi:10.1016/j.ijom.2018.03.022
   PubMed Web of Science ®Google Scholar
• Hanna TP, King WD, Thibodeau S, et al. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ. 2020;371. doi:10.1136/bmj.m4087
   Google Scholar